Context Therapeutics Inc. (CNTX) vs CervoMed Inc. (CRVO)
A side-by-side comparison of Context Therapeutics Inc. and CervoMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTX
Context Therapeutics Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 11:40 AM EDT
CRVO
CervoMed Inc.
$3.21HealthcareDelayed quote: Oct 6, 2026, 11:40 AM EDT
Total return — CNTX vs CRVO
growth of $100 · dividends reinvested · last 5yCNTX -93.4% (-41.9%/yr)CRVO -90.4% (-37.5%/yr)CRVO compounded faster over this window
CNTX CRVO
CNTX vs CRVO: by the numbers
- •CNTX is the larger company ($32M vs $30M market cap).
- •Both run net losses; CNTX's is the smaller (0.00% vs -9408.76% net margin).
Metrics side by side
Valuation
| Metric | CNTX | CRVO |
|---|---|---|
| P/S ratio | N/A | 92.02 |
| P/B ratio | 0.83 | 1.29 |
Profitability
| Metric | CNTX | CRVO |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -9408.76% |
| ROE | -120.40% | -132.18% |
| ROIC | -126.84% | -135.73% |
Growth (annualized)
| Metric | CNTX | CRVO |
|---|---|---|
| Total return CAGR (5Y) | N/A | -38.25% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.